Hormone priming in breast cancer: oestrogen priming has a detrimental effect on response in oestrogen receptor-negative patients.
L
L
Seymour
K
K
Meyer
W R
WR
Bezwoda
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004054:Diethylstilbestrol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D011960:Receptors, Estrogen / Q000187:drug effects*; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D011960:Receptors, Estrogen; D014750:Vincristine; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D008942:Mitoxantrone